(Q44516301)

3 December 2017

title

The PON1 M55L gene polymorphism is associated with reduced HDL-associated PAF-AH activity (English)

1 reference

3 December 2017

Anna I Kakafika

1

1 reference

3 December 2017

Stavroula Xenofontos

2

1 reference

3 December 2017

Vasilis Tsimihodimos

3

1 reference

3 December 2017

Afroditi P Tambaki

4

1 reference

3 December 2017

Evangelia S Lourida

5

1 reference

3 December 2017

Rigas Kalaitzidis

6

1 reference

3 December 2017

Marios A Cariolou

7

1 reference

3 December 2017

Moses Elisaf

8

1 reference

3 December 2017

Alexandros D Tselepis

9

1 reference

3 December 2017

publication date

16 July 2003

1 reference

Journal of Lipid Research

3 December 2017

published in

1 reference

3 December 2017

volume

44

1 reference

3 December 2017

issue

10

1 reference

3 December 2017

page(s)

1919-1926

1 reference

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300129-JLR200

HDL and the inflammatory response induced by LDL-derived oxidized phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300129-JLR200

Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300129-JLR200

Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300129-JLR200

A mutation in plasma platelet-activating factor acetylhydrolase (Val279-->Phe) is a genetic risk factor for stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300129-JLR200

Loss of activity of plasma platelet-activating factor acetylhydrolase due to a novel Gln281-->Arg mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300129-JLR200

The Ile198Thr and Ala379Val variants of plasmatic PAF-acetylhydrolase impair catalytical activities and are associated with atopy and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300129-JLR200

Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300129-JLR200

Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300129-JLR200

Platelet-activating factor acetylhydrolase, and not paraoxonase-1, is the oxidized phospholipid hydrolase of high density lipoprotein particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300129-JLR200

Identification of the G994--> T missense in exon 9 of the plasma platelet-activating factor acetylhydrolase gene as an independent risk factor for coronary artery disease in Japanese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300129-JLR200

Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300129-JLR200

Paraoxonase Gln-Arg(192) and Leu-Met(55) gene polymorphisms and enzyme activity in a population with a low rate of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300129-JLR200

Oxidized LDL and HDL: antagonists in atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300129-JLR200

Lipoproteins alter the catalytic behavior of the platelet-activating factor acetylhydrolase in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300129-JLR200

Apolipoprotein A-I promotes the formation of phosphatidylcholine core aldehydes that are hydrolyzed by paraoxonase (PON-1) during high density lipoprotein oxidation with a peroxynitrite donor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300129-JLR200

Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300129-JLR200

A paraoxonase gene polymorphism, PON 1 (55), as an independent risk factor for increased carotid intima-media thickness in middle-aged women

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300129-JLR200

Paraoxonase polymorphism (Gln192-Arg) is associated with coronary heart disease in Japanese noninsulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300129-JLR200

Polymorphisms of paraoxonase genes and low-density lipoprotein lipid peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300129-JLR200

A 192Arg variant of the human paraoxonase (HUMPONA) gene polymorphism is associated with an increased risk for coronary artery disease in the Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300129-JLR200

Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300129-JLR200

Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300129-JLR200

The paraoxonase Leu-Met54 and Gln-Arg191 gene polymorphisms are not associated with the risk of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300129-JLR200

10.1194/JLR.M300129-JLR200

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference